TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Study of Surgical Treatment (Open Appendicectomy) Versus Antibiotic Treatment (Ertapenem) in the Treatment of Acute Uncomplicated Appendicitis
Brief Summary: Appendicectomy has been the treatment of acute appendicitis for over a hundred years. Appendicectomy, however, includes operative and postoperative risks despite being a "routine" operation. At the same time other similar intra-abdominal infections, such as diverticulitis, are treated with antibiotics. There have been some encouraging reports on successful treatment of appendicitis with antibiotics and it has been estimated that operative treatment might be necessary for only 15 - 20 % of patients with acute appendicitis.

The aim of this randomized prospective study is to compare operative treatment (open appendicectomy) with conservative treatment with antibiotics (ertapenem, Invanz). Before randomization acute uncomplicated appendicitis is diagnosed with a CT scan.The hypothesis of the study is that the majority of patients with uncomplicated acute appendicitis can be treated successfully with antibiotics and unnecessary appendicectomies can be avoided.


Options:
A: Arm Label: Operative treatment; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Appendicectomy | Arm Label: Antibiotic treatment; Type: ACTIVE_COMPARATOR; Interventions: Drug: Ertapenem | Intervention Type: PROCEDURE; Name: Appendicectomy; Assigned to Arm(s): Operative treatment | Intervention Type: DRUG; Name: Ertapenem; Assigned to Arm(s): Antibiotic treatment
B: Arm Label: Low-dose CT; Type: EXPERIMENTAL; Interventions: Diagnostic Test: Diagnostic CT with low-dose radiation | Arm Label: Standard-dose CT; Type: ACTIVE_COMPARATOR; Interventions: Diagnostic Test: Diagnostic CT with standard-dose radiation | Intervention Type: DIAGNOSTIC_TEST; Name: Diagnostic CT with low-dose radiation; Assigned to Arm(s): Low-dose CT | Intervention Type: DIAGNOSTIC_TEST; Name: Diagnostic CT with standard-dose radiation; Assigned to Arm(s): Standard-dose CT
C: Arm Label: Diagnostic imaging; Type: EXPERIMENTAL; Interventions: Procedure: Diagnostic imaging | Arm Label: Repeat examination after observation; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Diagnostic imaging | Intervention Type: PROCEDURE; Name: Diagnostic imaging; Assigned to Arm(s): Diagnostic imaging, Repeat examination after observation
D: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Other: Omnipaque | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Other: Omnipaque | Intervention Type: OTHER; Name: Omnipaque; Assigned to Arm(s): 1, 2

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Study of Surgical Treatment (Open Appendicectomy) Versus Antibiotic Treatment (Ertapenem) in the Treatment of Acute Uncomplicated Appendicitis
Brief Summary: Appendicectomy has been the treatment of acute appendicitis for over a hundred years. Appendicectomy, however, includes operative and postoperative risks despite being a "routine" operation. At the same time other similar intra-abdominal infections, such as diverticulitis, are treated with antibiotics. There have been some encouraging reports on successful treatment of appendicitis with antibiotics and it has been estimated that operative treatment might be necessary for only 15 - 20 % of patients with acute appendicitis.

The aim of this randomized prospective study is to compare operative treatment (open appendicectomy) with conservative treatment with antibiotics (ertapenem, Invanz). Before randomization acute uncomplicated appendicitis is diagnosed with a CT scan.The hypothesis of the study is that the majority of patients with uncomplicated acute appendicitis can be treated successfully with antibiotics and unnecessary appendicectomies can be avoided.


Options:
A: Arm Label: A; Type: ACTIVE_COMPARATOR; Interventions: Procedure: appendectomy | Arm Label: B; Type: ACTIVE_COMPARATOR; Interventions: Drug: amoxicillin/clavulanate potassium | Intervention Type: DRUG; Name: amoxicillin/clavulanate potassium; Assigned to Arm(s): B | Intervention Type: PROCEDURE; Name: appendectomy; Assigned to Arm(s): A
B: Arm Label: Low-dose CT; Type: EXPERIMENTAL; Interventions: Radiation: Diagnostic CT | Arm Label: Standard-dose CT; Type: ACTIVE_COMPARATOR; Interventions: Radiation: Diagnostic CT | Intervention Type: RADIATION; Name: Diagnostic CT; Assigned to Arm(s): Low-dose CT | Intervention Type: RADIATION; Name: Diagnostic CT; Assigned to Arm(s): Standard-dose CT
C: Arm Label: Operative treatment; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Appendicectomy | Arm Label: Antibiotic treatment; Type: ACTIVE_COMPARATOR; Interventions: Drug: Ertapenem | Intervention Type: PROCEDURE; Name: Appendicectomy; Assigned to Arm(s): Operative treatment | Intervention Type: DRUG; Name: Ertapenem; Assigned to Arm(s): Antibiotic treatment
D: Arm Label: Low-dose CT; Type: EXPERIMENTAL; Interventions: Diagnostic Test: Diagnostic CT with low-dose radiation | Arm Label: Standard-dose CT; Type: ACTIVE_COMPARATOR; Interventions: Diagnostic Test: Diagnostic CT with standard-dose radiation | Intervention Type: DIAGNOSTIC_TEST; Name: Diagnostic CT with low-dose radiation; Assigned to Arm(s): Low-dose CT | Intervention Type: DIAGNOSTIC_TEST; Name: Diagnostic CT with standard-dose radiation; Assigned to Arm(s): Standard-dose CT

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Assessment of Dynamic Humeral Centering in Impingement Syndrome: a Randomized Clinical Trial
Brief Summary: The purpose of this study is to determine wether dynamic humeral centering is effective in patients with impingement syndrome of the shoulder


Options:
A: Arm Label: A; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Physical therapy method called Supervised Exercises | Arm Label: B; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Radial Extracorporeal Shockwave Therapy | Intervention Type: PROCEDURE; Name: Physical therapy method called Supervised Exercises; Assigned to Arm(s): A | Intervention Type: PROCEDURE; Name: Radial Extracorporeal Shockwave Therapy; Assigned to Arm(s): B
B: Arm Label: Active physiotherapy; Type: EXPERIMENTAL; Interventions: Procedure: Physiotherapy program | Arm Label: Placebo physiotherapy; Type: PLACEBO_COMPARATOR; Interventions: Procedure: Placebo physiotherapy treatment | Intervention Type: PROCEDURE; Name: Physiotherapy program; Assigned to Arm(s): Active physiotherapy | Intervention Type: PROCEDURE; Name: Placebo physiotherapy treatment; Assigned to Arm(s): Placebo physiotherapy
C: Arm Label: 1: Dynamic humeral centering; Type: EXPERIMENTAL; Interventions: Procedure: Dynamic humeral centering | Arm Label: 2: Nonspecific mobilisation; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Nonspecific mobilisation | Intervention Type: PROCEDURE; Name: Dynamic humeral centering; Assigned to Arm(s): 1: Dynamic humeral centering | Intervention Type: PROCEDURE; Name: Nonspecific mobilisation; Assigned to Arm(s): 2: Nonspecific mobilisation
D: Arm Label: No proprioception; Type: ACTIVE_COMPARATOR; Interventions: Other: Control, no Proprioception | Arm Label: Proprioceptive exercises; Type: EXPERIMENTAL; Interventions: Other: Experimental, Proprioceptive exercises | Intervention Type: OTHER; Name: Control, no Proprioception; Assigned to Arm(s): No proprioception | Intervention Type: OTHER; Name: Experimental, Proprioceptive exercises; Assigned to Arm(s): Proprioceptive exercises

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Double Blinded Randomized Placebo-controlled Trial of Intravenous QAX576 in the Treatment of Eosinophilic Esophagitis (EoE)
Brief Summary: This study is designed to investigate the effects of a 12 week course of intravenous QAX576 6mg/kg every 4 weeks in reducing the number of eosinophils in the esophagus of EoE patients by 75% or greater when compared with baseline.


Options:
A: Arm Label: Oral Budesonide Suspension (OBS); Type: EXPERIMENTAL; Interventions: Drug: Oral Budesonide Suspension (OBS) | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Oral Budesonide Suspension (OBS); Assigned to Arm(s): Oral Budesonide Suspension (OBS) | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: QAX576 placebo | Arm Label: QAX576; Type: ACTIVE_COMPARATOR; Interventions: Drug: QAX576 | Intervention Type: DRUG; Name: QAX576 placebo; Assigned to Arm(s): Placebo | Intervention Type: DRUG; Name: QAX576; Assigned to Arm(s): QAX576
C: Arm Label: IV ABT-308 in asthmatics; Type: EXPERIMENTAL; Interventions: Drug: ABT-308, Drug: Placebo | Arm Label: SC ABT-308 in asthmatics; Type: EXPERIMENTAL; Interventions: Drug: ABT-308, Drug: Placebo | Arm Label: IV ABT-308 in healthy volunteers; Type: EXPERIMENTAL; Interventions: Drug: ABT-308, Drug: Placebo | Intervention Type: DRUG; Name: ABT-308; Assigned to Arm(s): IV ABT-308 in asthmatics, IV ABT-308 in healthy volunteers | Intervention Type: DRUG; Name: ABT-308; Assigned to Arm(s): SC ABT-308 in asthmatics | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): IV ABT-308 in asthmatics, IV ABT-308 in healthy volunteers | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): SC ABT-308 in asthmatics
D: Arm Label: Viaskin Milk 500 mcg; Type: ACTIVE_COMPARATOR; Interventions: Drug: Viaskin Milk 500 mcg | Arm Label: Viaskin Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Viaskin Placebo | Intervention Type: DRUG; Name: Viaskin Milk 500 mcg; Assigned to Arm(s): Viaskin Milk 500 mcg | Intervention Type: DRUG; Name: Viaskin Placebo; Assigned to Arm(s): Viaskin Placebo

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A 12-Week, Randomised, Double-Blind, Placebo-Controlled, Parallel Group, Multinational, Phase IIb Study to Evaluate the Efficacy and Safety of 60mg AZD9668 Administered Orally Twice Daily to Subjects With Chronic Obstructive Pulmonary Disease (COPD) on Treatment With Budesonide/Formoterol
Brief Summary: The primary objective is to evaluate the efficacy of AZD9668 compared with placebo in symptomatic COPD patients by assessing the effects on lung function and symptoms of COPD


Options:
A: Intervention Type: DRUG; Name: Intravenous prednisolone; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Oral prednisolone; Assigned to Arm(s): N/A
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: AZD9668 | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: AZD9668; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): 2
C: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: MP-376 240 mg Twice Daily (BID); Type: EXPERIMENTAL; Interventions: Drug: MP-376 | Intervention Type: DRUG; Name: MP-376; Assigned to Arm(s): MP-376 240 mg Twice Daily (BID) | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: COPD subjects; Type: N/A; Interventions: Other: Novel endpoint determination | Arm Label: Smoker controls; Type: N/A; Interventions: Other: Novel endpoint determination | Arm Label: Non-smoker controls; Type: N/A; Interventions: Other: Novel endpoint determination | Intervention Type: OTHER; Name: Novel endpoint determination; Assigned to Arm(s): COPD subjects, Non-smoker controls, Smoker controls

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A 12-Week, Randomised, Double-Blind, Placebo-Controlled, Parallel Group, Multinational, Phase IIb Study to Evaluate the Efficacy and Safety of 60mg AZD9668 Administered Orally Twice Daily to Subjects With Chronic Obstructive Pulmonary Disease (COPD) on Treatment With Budesonide/Formoterol
Brief Summary: The primary objective is to evaluate the efficacy of AZD9668 compared with placebo in symptomatic COPD patients by assessing the effects on lung function and symptoms of COPD


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: AZD9668 | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: AZD9668; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): 2
B: Arm Label: Indacaterol 300 μg plus placebo to formoterol; Type: EXPERIMENTAL; Interventions: Drug: Indacaterol, Drug: Placebo to formoterol | Arm Label: Indacaterol 600 μg plus placebo to formoterol; Type: EXPERIMENTAL; Interventions: Drug: Indacaterol, Drug: Placebo to formoterol | Arm Label: Formoterol 12 μg plus placebo to indacaterol; Type: ACTIVE_COMPARATOR; Interventions: Drug: Formoterol, Drug: Placebo to indacaterol | Arm Label: Placebo to indacaterol plus placebo to formoterol; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo to indacaterol, Drug: Placebo to formoterol | Intervention Type: DRUG; Name: Indacaterol; Assigned to Arm(s): Indacaterol 300 μg plus placebo to formoterol, Indacaterol 600 μg plus placebo to formoterol | Intervention Type: DRUG; Name: Formoterol; Assigned to Arm(s): Formoterol 12 μg plus placebo to indacaterol | Intervention Type: DRUG; Name: Placebo to indacaterol; Assigned to Arm(s): Formoterol 12 μg plus placebo to indacaterol, Placebo to indacaterol plus placebo to formoterol | Intervention Type: DRUG; Name: Placebo to formoterol; Assigned to Arm(s): Indacaterol 300 μg plus placebo to formoterol, Indacaterol 600 μg plus placebo to formoterol, Placebo to indacaterol plus placebo to formoterol
C: Intervention Type: DRUG; Name: Tiotropium bromide 18mcg; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Fluticasone propionate/ salmeterol combination 50/500mcg; Assigned to Arm(s): N/A
D: Intervention Type: DRUG; Name: tiotropium; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): N/A

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Active Video Games and Sustainable Physical Activity
Brief Summary: The purpose of this study is to test the effect of active video game play on physical activity of 9-13 year old children in their natural home environments. We observe how much physical activity children engage in after receiving two different active Wii video games and for how long they play. Active video games offer promise of minimizing children's physical inactivity.


Options:
A: Arm Label: Enhanced NFN Home Program; Type: EXPERIMENTAL; Interventions: Behavioral: Experimental | Arm Label: Nurturing Family Network Home Visitation; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Experimental | Intervention Type: BEHAVIORAL; Name: Experimental; Assigned to Arm(s): Enhanced NFN Home Program, Nurturing Family Network Home Visitation
B: Arm Label: Active video game play; Type: EXPERIMENTAL; Interventions: Behavioral: Active video game play | Intervention Type: BEHAVIORAL; Name: Active video game play; Assigned to Arm(s): Active video game play
C: Arm Label: parent-targeted intervention; Type: EXPERIMENTAL; Interventions: Behavioral: multi-component/setting parent-targeted intervention | Arm Label: Primary Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: multi-component/setting parent-targeted intervention; Assigned to Arm(s): parent-targeted intervention
D: Arm Label: Team Nutriathlon intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Team Nutriathlon intervention | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Team Nutriathlon intervention; Assigned to Arm(s): Team Nutriathlon intervention

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Etude de Phase II évaluant l'immunogénicité et la tolérance d'un Vaccin inactivé Non adjuvanté Contre la Grippe A(H1N1)v Chez la Femme Enceinte
Brief Summary: The purpose of this study is to evaluate the immunogenicity and safety of an inactivated, non adjuvanted A(H1N1)v influenza vaccine in 120 pregnant women.

Study procedures will include 2 doses of vaccine, blood samples, cord blood samples at delivery and recording temperature and vaccine side effects in a memory aid for 7 days following each vaccination. Participants will be involved in study related procedures about 3 at 5 months.


Options:
A: Arm Label: vaccine; Type: EXPERIMENTAL; Interventions: Biological: Non-adjuvanted A(H1N1)v influenza vaccine | Intervention Type: BIOLOGICAL; Name: Non-adjuvanted A(H1N1)v influenza vaccine; Assigned to Arm(s): vaccine
B: Intervention Type: BIOLOGICAL; Name: Influenza vaccine; Assigned to Arm(s): N/A
C: Arm Label: treatment; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Lactobacillus rhamnosus, Biological: Influenza Virus Vaccine Live, Intranasal | Arm Label: placebo; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: placebo control, Biological: Influenza Virus Vaccine Live, Intranasal | Intervention Type: DIETARY_SUPPLEMENT; Name: Lactobacillus rhamnosus; Assigned to Arm(s): treatment | Intervention Type: DIETARY_SUPPLEMENT; Name: placebo control; Assigned to Arm(s): placebo | Intervention Type: BIOLOGICAL; Name: Influenza Virus Vaccine Live, Intranasal; Assigned to Arm(s): placebo, treatment
D: Arm Label: FluBlok; Type: EXPERIMENTAL; Interventions: Biological: FluBlok Influenza Vaccination | Arm Label: TIV (Fluzone); Type: ACTIVE_COMPARATOR; Interventions: Biological: TIV (Fluzone) Influenza Vaccination | Intervention Type: BIOLOGICAL; Name: FluBlok Influenza Vaccination; Assigned to Arm(s): FluBlok | Intervention Type: BIOLOGICAL; Name: TIV (Fluzone) Influenza Vaccination; Assigned to Arm(s): TIV (Fluzone)

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Behavioral Activation Enhanced Exercise Intervention:Pre-Pilot
Brief Summary: The purpose of this study is to test an exercise treatment that includes behavioral strategies to improve blood sugar control in women with type 2 diabetes who are depressed and overweight.This research study may lead to a potentially useful treatment for diabetes management when depression is present.


Options:
A: Arm Label: Exercise group; Type: EXPERIMENTAL; Interventions: Behavioral: Exercise group | Arm Label: Usual care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Exercise group; Assigned to Arm(s): Exercise group
B: Arm Label: Self-management group workshops; Type: EXPERIMENTAL; Interventions: Behavioral: Self-management group workshops | Arm Label: No treament (wait-list control); Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Self-management group workshops; Assigned to Arm(s): Self-management group workshops
C: Intervention Type: BEHAVIORAL; Name: Self-management of chronic illness; Assigned to Arm(s): N/A
D: Arm Label: SSRI + placebo; Type: ACTIVE_COMPARATOR; Interventions: Drug: SSRI + placebo | Arm Label: Escitalopram + Bupropion SR; Type: ACTIVE_COMPARATOR; Interventions: Drug: Escitalopram + Bupropion SR | Arm Label: Venlafaxine XR + Mirtazapine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Venlafaxine XR + Mirtazapine | Intervention Type: DRUG; Name: SSRI + placebo; Assigned to Arm(s): SSRI + placebo | Intervention Type: DRUG; Name: Escitalopram + Bupropion SR; Assigned to Arm(s): Escitalopram + Bupropion SR | Intervention Type: DRUG; Name: Venlafaxine XR + Mirtazapine; Assigned to Arm(s): Venlafaxine XR + Mirtazapine

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Behavioral Activation Enhanced Exercise Intervention:Pre-Pilot
Brief Summary: The purpose of this study is to test an exercise treatment that includes behavioral strategies to improve blood sugar control in women with type 2 diabetes who are depressed and overweight.This research study may lead to a potentially useful treatment for diabetes management when depression is present.


Options:
A: Arm Label: Conventional care, controlgroup; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: integrated health care chain; Type: EXPERIMENTAL; Interventions: Other: integrated health care chain | Intervention Type: OTHER; Name: integrated health care chain; Assigned to Arm(s): integrated health care chain
B: Arm Label: Nurse case management and self-management support; Type: EXPERIMENTAL; Interventions: Other: Nurse case management and self-management support | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Nurse case management and self-management support; Assigned to Arm(s): Nurse case management and self-management support
C: Arm Label: Diabetes-Specific CBT (DS-CBT); Type: EXPERIMENTAL; Interventions: Behavioral: Diabetes-Specific CBT (DS-CBT) | Arm Label: Standard Diabetes Education; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Standard Diabetes Education | Intervention Type: BEHAVIORAL; Name: Diabetes-Specific CBT (DS-CBT); Assigned to Arm(s): Diabetes-Specific CBT (DS-CBT) | Intervention Type: BEHAVIORAL; Name: Standard Diabetes Education; Assigned to Arm(s): Standard Diabetes Education
D: Arm Label: Exercise group; Type: EXPERIMENTAL; Interventions: Behavioral: Exercise group | Arm Label: Usual care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Exercise group; Assigned to Arm(s): Exercise group

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Behavioral Activation Enhanced Exercise Intervention:Pre-Pilot
Brief Summary: The purpose of this study is to test an exercise treatment that includes behavioral strategies to improve blood sugar control in women with type 2 diabetes who are depressed and overweight.This research study may lead to a potentially useful treatment for diabetes management when depression is present.


Options:
A: Arm Label: B; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Treatment as usual | Arm Label: A; Type: EXPERIMENTAL; Interventions: Behavioral: Nurse-led case management | Intervention Type: BEHAVIORAL; Name: Nurse-led case management; Assigned to Arm(s): A | Intervention Type: BEHAVIORAL; Name: Treatment as usual; Assigned to Arm(s): B
B: Arm Label: Enhanced Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Staged Care Management; Type: EXPERIMENTAL; Interventions: Behavioral: Medication Care Management (MCM), Behavioral: Cognitive-Behavioral Therapy (CBT) | Intervention Type: BEHAVIORAL; Name: Medication Care Management (MCM); Assigned to Arm(s): Staged Care Management | Intervention Type: BEHAVIORAL; Name: Cognitive-Behavioral Therapy (CBT); Assigned to Arm(s): Staged Care Management
C: Arm Label: Exercise group; Type: EXPERIMENTAL; Interventions: Behavioral: Exercise group | Arm Label: Usual care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Exercise group; Assigned to Arm(s): Exercise group
D: Arm Label: Enhanced treatment as usual; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Enhanced treatment as usual plus adherence training | Arm Label: CBT-AD; Type: EXPERIMENTAL; Interventions: Behavioral: Enhanced treatment as usual plus CBT-AD | Intervention Type: BEHAVIORAL; Name: Enhanced treatment as usual plus adherence training; Assigned to Arm(s): Enhanced treatment as usual | Intervention Type: BEHAVIORAL; Name: Enhanced treatment as usual plus CBT-AD; Assigned to Arm(s): CBT-AD

Answer: C